SLS

SELLAS Life Sciences Group, Inc.

Pharmaceutical PreparationsNasdaqNon-accelerated filer<br>Smaller reporting company

Total Trades

7

Buys

4

Sells

3

Largest Trade

$100K–$500K

Insiders

6

Institutional Funds

87

Inst. Value

$1M+

Activist Filings

7

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Kalin Katherine BachDirectorBUY$100K–$500K63K$1.59Nov 21, 2025
VAN NOSTRAND ROBERT LDirectorBUY$1K–$15K10K$1.48Jun 13, 2025
Wasman JaneDirectorBUY$15K–$50K20K$1.69Jun 2, 2025
Kalin Katherine BachDirectorBUY$15K–$50K20K$1.80May 22, 2025
Stergiou Angelos M.President and CEOSELL$15K–$50K6K$2.61Dec 5, 2022
Burns John ThomasSenior VPSELL$1K–$15K1K$2.59Dec 5, 2022
WOOD BARBARA AEVPSELL$1K–$15K2K$2.59Dec 5, 2022
🔓Seeing ranges? Sign in for exact trade values — free forever

Institutional Ownership

13F filings as of Dec 31, 2025 · 87 funds holding

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

Highbridge Capital Management, LLC

SC 13G/A · Jan 30, 2026

3.7%

6.5M shares

Anson Funds Management LP

SC 13G · Nov 14, 2025

5.7%

6.0M shares

BlackRock, Inc.

SC 13G · Oct 17, 2025

5.4%

5.7M shares

Anson Funds Management LP

SC 13G/A · Aug 15, 2025

4.9%

5.2M shares

The Vanguard Group

SC 13G · Jul 29, 2025

6.7%

6.7M shares

Anson Funds Management LP

SC 13G · May 15, 2025

8.3%

7.6M shares

Highbridge Capital Management, LLC

SC 13G/A · Nov 8, 2024

9.9%

13.3M shares

View on Google Finance →